Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$27.8B
sum of reported positions
Reported positions
934
Changes vs prior quarter
1068
158 new · 177 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 342 measured positions in 8 quarters, the typical new or larger position finished −3.7 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $27.8B |
| Positions | 953 | 934 |
| Biggest line | — | NVIDIA 6% |
| 656K |
| $757M |
| 2.7% |
| 1.74M | $648M | 2.3% |
| 1.73M | $521M | 1.9% |
| 2.22M | $396M | 1.4% |
| 2.56M | $394M | 1.4% |
| 1.62M | $386M | 1.4% |
| 482K | $368M | 1.3% |
| 2.18M | $316M | 1.1% |
| 2.27M | $296M | 1.1% |
| 3.4M | $296M | 1.1% |
| 145K | $287M | 1.0% |
| 3.49M | $269M | 1.0% |
| 117K | $265M | 1.0% |
| 2.77M | $251M | 0.9% |
| 914K | $238M | 0.9% |
| 284K | $236M | 0.8% |
| 921K | $232M | 0.8% |
| 533K | $231M | 0.8% |
| 606K | $229M | 0.8% |
| 3.42M | $219M | 0.8% |
| 4.14M | $213M | 0.8% |
| 448K | $200M | 0.7% |
BrightSpring Health Services (BTSG)
12K shares
American Coastal Insurance (ACIC)
151K → 78K shares (−49%)
Agios Pharmaceuticals (AGIO)
29K → 23K shares (−20%)
Houlihan Lokey (HLI)
32K → 6,335 shares (−80%)
Selectquote (SLQT)
871K → 1.01M shares (+16%)
Arq (ARQ)
351K → 329K shares (−6%)
Primis Financial (FRST)
40K → 51K shares (+27%)
Rocket Lab (RKLB)
8,125 shares
Amneal Pharmaceuticals (AMRX)
48K shares
Talos Energy, Inc. (TALO)
63K shares
Adtran Holdings (ADTN)
462K → 58K shares (−87%)
Atn International (ATNI)
32K → 30K shares (−5%)
Nu Skin Enterprises (NUS)
152K shares
Tanger Factory Outlet Centers, Inc. (SKT)
77K → 20K shares (−74%)
Figma (FIG)
43K shares
Everquote (EVER)
238K → 33K shares (−86%)
Curiositystream (CURI)
24K → 293K shares (+1133%)
National Health Investors, Inc. (NHI)
10K shares
Griffon Corporation (GFF)
8,354 → 7,890 shares (−6%)
Orion Group (ORN)
263K → 46K shares (−83%)
Lifetime Brands (LCUT)
90K shares
Urogen Pharma (URGN)
33K → 21K shares (−36%)
Eagle Bancorp Montana (EBMT)
32K shares
Graftech International (EAF)
128K shares
Iradimed (IRMD)
8,684 → 7,872 shares (−9%)
